Puro Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Ernakulam, Kerala, India, established in 1963.
1963 Ernakulam, Kerala, India Struck Off
Last Updated:
Access Report
About Puro Pharma Private Limited

Puro Pharma Private Limited, a struck off private limited company, was established on 16 June 1963 in Ernakulam, Kerala, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231KL1963PTC002018. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.20 M.

Its leadership includes Bobby Jose (Director), Jimmy Jose (Director). It holds no open charges and ₹40.00 K settled loans. It is based at 17 Krishna Viharpanampilly Nagar Kochi, Ernakulam, Kerala, 682036.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231KL1963PTC002018

  • Registration Number

    002018

  • Incorporation Date

    16 June 1963

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 62 Year, 8 Months
  • Satisfied Charges ₹ 40.00 K
Company report

Puro Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Puro Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Puro Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Bobby Jose Director 11 Apr 1995 Current
Jimmy Jose Director 11 Apr 1995 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Puro Pharma.

Enhance accessibility to Puro Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Puro Pharma revenue growth over time
Puro Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Puro Pharma?

Unlock access to Puro Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹40,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.00 Cr
Latest Charge Details
Date Lender Amount Status
17 Jan 1970 Canara Bank ₹0.04 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Puro Pharma?

Unlock and access historical data on people associated with Puro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Puro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Puro Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Puro Pharma
Recent Activity within the Organization
  • Charges

    A charge registered on 17 Jan 1970 via Charge ID 90021321 with Canara Bank was fully satisfied on 06 Apr 2011. was recorded as a recent event.

  • Director Appointment

    Bobby Jose was appointed as a Director was appointed as a Director on 11 Apr 1995 & has been associated with this company since 30 years 10 months . was recorded as a recent event.

  • Director Appointment

    Jimmy Jose was appointed as a Director was appointed as a Director on 11 Apr 1995 & has been associated with this company since 30 years 10 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 0.04 M with Charge ID 90021321 was registered on 17 Jan 1970. was documented.

  • Company Incorporation

    Puro Pharma Private Limited was registered on 16 Jun 1963 with Roc Ernakulam & aged 62 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Puro Pharma Private Limited?

The CIN of Puro Pharma Private Limited is U24231KL1963PTC002018.

Where is Puro Pharma Private Limited headquartered?

Puro Pharma Private Limited is headquartered at 17 Krishna Viharpanampilly Nagar Kochi, Ernakulam, Kerala, 682036.

When was Puro Pharma Private Limited incorporated?

Puro Pharma Private Limited was incorporated on 16 June 1963.

Who are the current directors of Puro Pharma Private Limited?

The current directors of Puro Pharma Private Limited are

What is the primary industry of Puro Pharma Private Limited?

The primary industry of Puro Pharma Private Limited is Chemicals.

Is Puro Pharma Private Limited a listed company?

Puro Pharma Private Limited is unlisted.

What is the capital structure of Puro Pharma Private Limited?

The authorized capital of Puro Pharma Private Limited is ₹0.30 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available